Catalent

Global, cGMP Micronizing and Milling for the Pharmaceutical Industry

Catalent Acquires Accucaps to Expand Softigel Development and Manufacturing

Global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products Catalent has announced that the company has agreed to acquire...

Catalent Acquires Accucaps to Expand Softigel Development and Manufacturing

Catalent Biologics Signs a Licence Agreement with Triphase Accelerator Corporation to Advance Smartag ADC to Clinic

Catalent has announced that Triphase Accelerator Corporation will obtain worldwide rights to further develop its proprietary CD22-4AP Antibody-Drug Conjugate (ADC), which has been developed...

Catalent Biologics Signs a Licence Agreement with Triphase Accelerator Corporation to Advance Smartag ADC to Clinic

Singapore Clinical Supply Facility to Receive $4.6m Investment from Catalent for Expansion

Catalent has announced it will build a new, flexible GMP space at its Singapore facility with an investment of...

Singapore Clinical Supply Facility to Receive $4.6m Investment from Catalent for Expansion

Catalent Invests $4.6m to Further Expand Asia–Pacific Clinical Trials Hub in Singapore

Catalent Pharma Solutions has announced that it will invest $4.6m to further expand its Singapore clinical supply facility by building new flexible GMP space for secondary packaging, doubling...

Catalent Invests $4.6m to Further Expand Asia–Pacific Clinical Trials Hub in Singapore

Catalent Biologics and Cerenis Therapeutics Announce Phase III Trial of CER-001 in Europe and North America

Catalent Pharma Solutions has announced that Cerenis Therapeutics has advanced its leading clinical candidate, CER-001, into Phase III clinical studies across Europe and North America....

Catalent Biologics and Cerenis Therapeutics Announce Phase III Trial of CER-001 in Europe and North America